Steven R Goldsmith Selected Research

Antidiuretic Hormone Receptor Antagonists

2/2021	Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial.
5/2016	A new approach to treatment of acute heart failure.
10/2013	Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations.
7/2010	Treatment options for hyponatremia in heart failure.
6/2009	Treatment options for hyponatremia in heart failure.
7/2006	Is there a cardiovascular rationale for the use of combined vasopressin V1a/V2 receptor antagonists?
6/2006	Vasopressin receptor antagonists: mechanisms of action and potential effects in heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven R Goldsmith Research Topics

Disease

35	Heart Failure 02/2021 - 09/2002
9	Hyponatremia 01/2021 - 05/2005
7	Body Weight (Weight, Body) 02/2021 - 10/2008
6	Dyspnea (Shortness of Breath) 01/2021 - 07/2015
2	Hypertrophy 01/2021 - 09/2002
2	Disease Progression 07/2019 - 06/2006
2	Edema (Dropsy) 07/2015 - 06/2009
2	Cardio-Renal Syndrome 02/2015 - 03/2010
2	Hypertension (High Blood Pressure) 03/2013 - 05/2010
2	Left Ventricular Dysfunction 07/2004 - 09/2002
1	Alkalosis 01/2018
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Heart Arrest (Cardiac Arrest) 01/2017
1	Exanthema (Rash) 05/2015
1	Weight Loss (Weight Reduction) 12/2012
1	Obesity 11/2012
1	Ventricular Remodeling 06/2006

Drug/Important Bio-Agent (IBA)

11	Arginine Vasopressin (Argipressin)IBA 01/2021 - 09/2002
10	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 02/2021 - 05/2005
9	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 02/2021 - 05/2006
9	Vasopressins (Vasopressin)IBA 01/2021 - 11/2005
9	DiureticsIBA 12/2017 - 03/2011
8	Tolvaptan FDA Link 10/2017 - 05/2005
7	Antidiuretic Hormone Receptor AntagonistsIBA 02/2021 - 06/2006
4	conivaptan (Vaprisol)FDA Link 01/2018 - 05/2005
4	SodiumIBA 12/2017 - 05/2005
4	Furosemide (Lasix)FDA LinkGeneric 10/2017 - 05/2005
4	ElectrolytesIBA 10/2013 - 05/2005
2	CreatinineIBA 02/2021 - 12/2012
2	Urea (Carbamide)FDA LinkGeneric 02/2021 - 05/2005
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2013 - 11/2007
1	NitrogenIBA 02/2021
1	Angiotensin IIIBA 01/2021
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2018
1	Allopurinol (Remid)FDA LinkGeneric 05/2015
1	Xanthine OxidaseIBA 05/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2013
1	Dopamine (Intropin)FDA LinkGeneric 12/2013
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2005
1	lixivaptanIBA 05/2005
1	Lithium Carbonate (Eskalith)FDA LinkGeneric 05/2005
1	Demeclocycline (Declomycin)FDA LinkGeneric 05/2005
1	Hypertonic Saline SolutionIBA 05/2005

Therapy/Procedure

19	Therapeutics 02/2021 - 09/2002
1	Patient Readmission 12/2017
1	Induced Hypothermia 01/2017
1	Drug Therapy (Chemotherapy) 05/2010